Biotherapeutics News for February 2020

The Native Antigen Company Introduces Novel Coronavirus Antigens The Native Antigen Company Introduces Novel Coronavirus Antigens

Newly developed recombinant antigens derived specifically from 2019-nCoV for use in infectious disease research, and assay and vaccine development
12 February, 2020